BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/24/2021 7:26:32 AM | Browse: 223 | Download: 440
Publication Name World Journal of Clinical Cases
Manuscript ID 63972
Country China
Received
2021-03-04 03:41
Peer-Review Started
2021-03-04 03:41
To Make the First Decision
Return for Revision
2021-04-06 12:44
Revised
2021-04-08 14:46
Second Decision
2021-05-19 09:04
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-05-19 11:54
Articles in Press
2021-05-19 11:54
Publication Fee Transferred
Edit the Manuscript by Language Editor
2021-06-01 22:54
Typeset the Manuscript
2021-06-15 14:03
Publish the Manuscript Online
2021-06-24 07:26
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Basic Study
Article Title Anti-tumor effects of SMAC in ECA109 cells by regulating the expression of the inhibitor of apoptosis protein family
Manuscript Source Unsolicited Manuscript
All Author List Ning Jiang, Wei-Quan Zhang, Hong Dong, Ying-Tao Hao, Li-Ming Zhang, Lei Shan, Xiao-Dong Yang and Chuan-Liang Peng
ORCID
Author(s) ORCID Number
Ning Jiang http://orcid.org/0000-0002-4613-5029
Wei-Quan Zhang http://orcid.org/0000-0002-3078-8340
Hong Dong http://orcid.org/0000-0002-6765-0222
Ying-Tao Hao http://orcid.org/0000-0002-7474-6484
Li-Ming Zhang http://orcid.org/0000-0001-7768-2618
Lei Shan http://orcid.org/0000-0001-5438-6066
Xiao-Dong Yang http://orcid.org/0000-0003-2992-1500
Chuan-Liang Peng http://orcid.org/0000-0003-2275-4789
Funding Agency and Grant Number
Corresponding Author Chuan-Liang Peng, MD, Chief Physician, Department of Thoracic Surgery, the Second Hospital of Shandong University, No. 247 Beiyuan Street, Jinan 250100, Shandong Province, China. pechuliang@126.com
Key Words SMAC; Esophageal cancer; ECA109 cell; Apoptosis protein; Inhibitor of apoptosis proteins family
Core Tip The poor prognosis and rising incidence of esophageal cancer highlight the need for improved therapeutic that are essential prior to treatment. The aim of this study is to explore the mechanisms by which SMAC (second mitochondrial activator of caspases) mimetics inhibit proliferation and induce apoptosis in ECA109 esophageal cancer cells. The findings support the hypothesis that LCL161 can inhibit proliferation and induce apoptosis in esophageal cancer cells ECA109 by regulating the expression of inhibitor of apoptosis proteins family, suggesting that it has potential to be an effective treatment for esophageal squamous cell carcinoma.
Publish Date 2021-06-24 07:26
Citation Jiang N, Zhang WQ, Dong H, Hao YT, Zhang LM, Shan L, Yang XD, Peng CL. Anti-tumor effects of SMAC in ECA109 cells by regulating the expression of the inhibitor of apoptosis protein family. World J Clin Cases 2021; 9(19): 5019-5027
URL https://www.wjgnet.com/2307-8960/full/v9/i19/5019.htm
DOI https://dx.doi.org/10.12998/wjcc.v9.i19.5019
Full Article (PDF) WJCC-9-5019.pdf
Full Article (Word) WJCC-9-5019.docx
Manuscript File 63972_Auto_Edited-JPY_WangTQ.docx
Answering Reviewers 63972-Answering reviewers.pdf
Audio Core Tip 63972-Audio core tip.m4a
Biostatistics Review Certificate 63972-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 63972-Conflict-of-interest statement.pdf
Copyright License Agreement 63972-Copyright license agreement.pdf
Institutional Review Board Approval Form or Document 63972-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate 63972-Language certificate.pdf
Peer-review Report 63972-Peer-review(s).pdf
Scientific Misconduct Check 63972-Bing-Wang JL-1.jpg
Scientific Misconduct Check 63972-Scientific misconduct check.pdf
Scientific Editor Work List 63972-Scientific editor work list.pdf